
-
DoorDash agrees £2.9 billion takeover of Deliveroo
-
Dollar recovers some losses, stocks mixed as traders eye tariff deals
-
Hamas says no point in further Gaza truce talks
-
'Aussiewood' courts Hollywood as Trump film tariffs loom
-
How a privately owned city in Kenya took on corrupt officials
-
Ozempic slimming craze sweeps Kosovo despite side effects
-
Drone strikes rock Port Sudan in third day of attacks
-
US President Trump and Canada's Carney set for high-stakes meeting
-
Philips turns in a profit but China, tariffs weigh
-
Drones hit Port Sudan airport in third day of attacks
-
Australian mushroom murder suspect rejected help preparing meal: witness
-
Jokic-inspired Nuggets stun Thunder, Knicks down Celtics
-
India's woman fighter pilot trailblazer eyes space
-
'Shared dream': China celebrates Zhao's world snooker breakthrough
-
Wait for Vatican white smoke fires up social media
-
Sinner leading the charge in golden era for Italian tennis
-
Donnarumma stands tall on PSG's Champions League run
-
Dollar recovers some losses, stocks gain as traders eye tariff deals
-
US aid cuts push Bangladesh's health sector to the edge
-
Prayers, pride in Philippine papal contender's hometown
-
Germany's Merz to launch new govt in times of Trump turbulence
-
Brunson sparks Knicks in comeback win over Celtics
-
All roads lead to Rome Open for Sinner after doping ban
-
French Resistance members reunited 80 years after end of WWII
-
Arsenal must 'stick together' in PSG showdown: Odegaard
-
New Zealand PM proposes banning under-16s from social media
-
Agronomics Limited - Meatable and TruMeat Forge Alliance
-
Pulsar Helium Announces Results of 2025 Annual General and Special Meeting of Shareholders
-
Helium One Global Ltd - Jackson-2 Well Drilled to TD & Free Gas Confirmed
-
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
-
Rihanna reveals third pregnancy on Met Gala night
-
Trump orders curb on virus research he blames for Covid pandemic
-
'Makes no sense': Hollywood shocked by Trump's film tariffs announcement
-
First day of jury selection wraps in Sean Combs sex crimes trial
-
Dominican Republic reports sharp rise in Haitian migrant deportations
-
Mennonite communities raise hackles in Peruvian Amazon
-
Dominican Republican reports sharp rise in Haitian migrant deportations
-
Stars shine at Met Gala, showcasing Black dandyism
-
Ireland captain Doris doubtful for Lions tour due to shoulder injury
-
Pentagon chief orders 20% cut in number of top officers
-
'New superstar' Zhao's world title heralds Chinese snooker revolution
-
OpenAI abandons plan to become for-profit company
-
Ford sees $1.5 bn tariff hit this year, suspends 2025 forecast
-
Snooker star Zhao: from ban to Chinese sporting history
-
Zhao makes history as China's first World Snooker champion
-
Brazilian ritual root gets second life as potential anti-depressant
-
Israel says 'most' Gazans to be displaced in expanded operation
-
Israel strikes Yemen after Huthi attack on Ben Gurion airport
-
'It's time': Popovich passes Spurs torch to Johnson
-
Cummins heroics in vain as rain forces Hyderabad out of IPL playoff race

Philips turns in a profit but China, tariffs weigh
Dutch medical device maker Philips reported a net profit for the first time in three quarters Tuesday despite weak sales in China but warned of "intensified" uncertainties due to tariffs.
Net profits came in at 72 million euros ($82 million), compared to a net loss of 998 million euros in the same quarter last year and 333 million euros in the fourth quarter of 2024.
"It's an encouraging start to the year," the firm's chief executive Roy Jakobs told reporters.
Jakobs predicted that the second half of the year would be stronger for the firm than the first half.
"In an uncertain macro environment that has intensified due to the potential impact of tariffs, we are focused on what we can control," he added.
The company estimated a hit of between 250-300 million euros from tariffs over the year.
Philips maintained its forecast for between one and three percent growth in sales for 2025, but slightly cut its projection for earnings before special items (EBITA).
The firm pointed to a two-percent growth in orders globally, with China again proving a drag. Without China, the order growth would have been four percent, Philips said.
However, global sales were down two percent compared to the same quarter last year due to a "double-digit decline" in China, the firm said.
Philips has previous warned that a slowing Chinese economy was hurting consumer demand for products and the government's anti-corruption drive was hitting procurement.
Once famous for making lightbulbs and televisions among other products, Amsterdam-based Philips in recent years has sold off subsidiaries to focus on medical care technology.
Since 2021, the company has been battling a series of crises over its DreamStation machines for sleep apnoea, a disorder in which breathing stops and starts during sleep.
Millions of devices were recalled over concerns that users were at risk of inhaling pieces of noise-cancelling foams and fears it could potentially cause cancer.
In April 2024, it announced it had reached a $1.1 billion deal to settle US lawsuits over the faulty machines.
P.Costa--AMWN